Tumor-infiltrating lymphocytes therapy

https://biomed.news/nitpo

8000

signing up

signing up %e% …

Selectors@biomed.news sent email to %e%.

done

The subscription service is down right now. So sorry!

I can’t sign up “%e%”.

Selectors@biomed.news has emailed %e%.

%e% has been signed up to %r%.

max

disable

Set email:

Here are the seven most related reports.

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-spamet“Spatial metabolomics of T cells”, ∼ 7 p.p.i. ∼ 7 papers per issue

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-imseme“Immunosenescence and T cell metabolism”, ∼ 19 p.p.i. ∼ 19 papers per issue

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-carter“CAR-T Therapies”, ∼ 44 p.p.i. ∼ 44 papers per issue

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-mimcat“Mitochondrial metabolism and cancer therapeutic innovation”,

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-imicid“Immunometabolism of infection, cancer and immune-mediated disease”, ∼ 31 p.p.i. ∼ 31 papers per issue

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-camemi“Mitochondrial metabolism in cancer”, ∼ 48 p.p.i. ∼ 48 papers per issue

0000‒00‒00

Signing up

0000‒00‒00

Signed up

bims-tumhet“Tumor heterogeneity”, ∼ 7 p.p.i. ∼ 7 papers per issue